Description
This vial pairs two peptides that act on different points of the growth-hormone axis: CJC-1295 without DAC (also called modified GRF 1-29), a GHRH-receptor agonist, and ipamorelin, a selective ghrelin-receptor (GHS-R1a) agonist.
Research context
Combining a GHRH analogue with a GHS-R agonist is a common model for studying synergistic, pulsatile GH release. Pre-blending keeps the ratio fixed between experiments.
Specifications
| Amount per vial | 10 mg total (5 mg + 5 mg) |
|---|---|
| Form | Lyophilized (freeze-dried) powder in a sealed glass vial |
| Storage | Store sealed vials at −20 °C, away from light. Once reconstituted, keep at 2–8 °C. |
| Intended use | In-vitro and laboratory research only |
For laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or supplement. Sold only to qualified researchers who accept our Research Use Policy.
Reviews
There are no reviews yet.